Euvax B

Euvax B. PDF fileEuvax B consists of highly purifiednon infectious particles of Hepatitis B surface antigen (HBsAg) adsorbed onto aluminum salts as an adjuvant and preserved with thimerosal It is a recombinant DNA hepatitis B vaccine derived from HBsAg produced by DNA recombinant technology in yeast cells (Saccharomyces cerevisiae) The vaccine meets the WHO requirements for recombinant.

PDF fileENGERIXB Hepatitis B vaccine (recombinant) 05 mL and 10 mL suspensions of 20 mcg/mL hepatitis B surface antigen for injection Active immunizing agent against infection caused by allknown subtypes of hepatitis B virus ATC Code J07BC01 GlaxoSmithKline Inc 7333 Mississauga Road Mississauga Ontario L5N 6L4 gskca Date of Initial Approval November06.

Immunogenicity of a Recombinant Hepatitis B Vaccine (Euvax

The hepatitis B vaccine is an injection (or shot) that is generally given in the arm as a threedose series on a 0 1 and 6month schedule Alternative schedules may be considered noting that a third dose at 6 months meeting minimum intervals between doses is needed for maximum longterm protection.

Hepatitis B Foundation: Hepatitis B Vaccine Schedules

PDF fileDESCRIPTION Euvax B vaccine is a white slightly opalescent suspension It is a subunit viral vaccine containing highly purified noninfectious particles of hepatitis B surface antigen (HBsAg) adsorbed onto Aluminum salts as an adjuvant Thiomersal (001% w/v) is used as a preservative It is a DNA recombinant vaccine derived from HBsAg produced by DNA recombinant.

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights

PDF fileEuvax B je indikovan zaaktivnuimunizaciju protiv infekcije koju izazivaju svi poznati podtipovi hepatitis B virusa Nakon vakcinacije dolazi do stvaranja specifičnih antitela na površinski antigen virusa hepatitisa B (HBsAg) 2 Šta treba da znate pre nego što primitelek Euvax B LekEuvax B ne smete primati Ukoliko ste alergični (preosetljivi) na aktivnu supstancu ili na bilo koju od.